• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Immunomedics Inc. (IMMU)

    -NasdaqGM
    5.35 Up 0.07(1.33%) Jan 30, 4:00PM EST
    |After Hours : 5.35 0.00 (0.00%) Jan 30, 5:18PM EST
    Add to Portfolio
    Prev Close:5.28
    Open:5.20
    Bid:4.80 x 400
    Ask:N/A
    1y Target Est:7.00
    Beta:-0.29
    Next Earnings Date:N/A
    Day's Range:5.16 - 5.48
    52wk Range:3.04 - 5.48
    Volume:1,503,152
    Avg Vol (3m):713,876
    Market Cap:498.26M
    P/E (ttm):N/A
    EPS (ttm):-0.49
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMMU

    Comparison

    Symbol% ChgMkt Cap
    IMMUUp 1.33%498.26M
    BIIBUp 10.17%91.64B
    GSKDown 2.57%105.78B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):106.54
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.48
    Quarterly EPS Est (Dec-14) :-0.13
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback